| 351 |
19106626 | The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells. | 2009 Jan 1 |
2 |
| 352 |
19560877 | Is it the time for metformin to take place in adjuvant treatment of Her-2 positive breast cancer? Teaching new tricks to old dogs. | 2009 Oct |
1 |
| 353 |
19574203 | mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb). | 2009 Jul |
1 |
| 354 |
19679549 | Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. | 2009 Aug 15 |
1 |
| 355 |
19858366 | LKB1 and mammalian target of rapamycin as predictive factors for the anticancer efficacy of metformin. | 2009 Dec 1 |
1 |
| 356 |
19858375 | If mammalian target of metformin indirectly is mammalian target of rapamycin, then the insulin-like growth factor-1 receptor axis will audit the efficacy of metformin in cancer clinical trials. | 2009 Nov 20 |
2 |
| 357 |
18678646 | A gene signature-based approach identifies mTOR as a regulator of p73. | 2008 Oct |
1 |
| 358 |
18803638 | Metformin suppresses intestinal polyp growth in ApcMin/+ mice. | 2008 Nov |
1 |
| 359 |
17698034 | Activation of mammalian target of rapamycin complex 1 and insulin resistance induced by palmitate in hepatocytes. | 2007 Oct 12 |
1 |
| 360 |
18006825 | Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. | 2007 Nov 15 |
5 |
| 361 |
16354680 | Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. | 2006 Jan |
1 |